Axel Wester

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Outcomes associated with secondary spontaneous bacterial peritonitis (SBP) prophylaxis after hospital discharge in a nation-wide Swedish cohort.

Outcomes associated with secondary spontaneous bacterial peritonitis (SBP) prophylaxis after hospital discharge in a nation-wide Swedish cohort.

Journal: Scandinavian journal of gastroenterology

Published: June 30, 2026

Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study.

Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study.

Journal: Clinical and molecular hepatology

Published: March 05, 2026

Risk of infection shortly before and after a diagnosis of liver cirrhosis: a nationwide, population-based study in Sweden.

Risk of infection shortly before and after a diagnosis of liver cirrhosis: a nationwide, population-based study in Sweden.

Journal: European journal of internal medicine

Published: November 12, 2025

Twofold increased risk of coronary artery disease after liver transplantation: A nationwide Swedish cohort of 2925 patients.

Twofold increased risk of coronary artery disease after liver transplantation: A nationwide Swedish cohort of 2925 patients.

Journal: Annals of hepatology

Published: October 16, 2025

Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in Sweden.

Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in Sweden.

Journal: Scandinavian journal of gastroenterology

Published: August 11, 2025

Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in Sweden.

Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in Sweden.

Journal: BMJ public health

Published: June 02, 2025

Reply to "Improving risk estimation in MASLD: Competing events and liver function reserve".

Reply to "Improving risk estimation in MASLD: Competing events and liver function reserve".

Journal: Journal of hepatology

Published: May 06, 2025

Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study.

Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study.

Journal: European journal of internal medicine

Published: November 04, 2024

Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes.

Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes.

Journal: Journal of hepatology

Published: September 20, 2024

Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden.

Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden.

Journal: Journal of hepatology

Published: August 08, 2024

Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry.

Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry.

Journal: Journal of the American Heart Association

Published: June 27, 2024

Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients.

Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients.

Journal: Alimentary pharmacology & therapeutics

Published: June 06, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026